protein

Recombinant Human M-CSF, Animal-Free Protein

AFL216

1 mg (also 5 ug, 25 ug, 500 ug)

8175 USD

AFL216

Recombinant Human M-CSF, Animal-Free Protein

1 mg (also 5 ug, 25 ug, 500 ug)

The Recombinant Human M-CSF, Animal-Free Protein from R&D Systems is derived from E. coli. The Recombinant Human M-CSF, Animal-Free Protein has been validated for the following applications: Bioactivity.

M-CSF

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Human

37 kDa, non-reducing conditions

18.5 kDa (monomer)

CSF1

Measured in a cell proliferation assay using M-NFS-60 mouse myelogenous leukemia lymphoblast cells. Nakoinz, I. et al . (1990) J. Immunol. 145 :860. The ED50 for this effect is 0.5-1.5 ng/mL. The specific activity of Recombinant Human M-CSF is 6.0 x 107 IU/mg, which is calibrated against the human M-CSF WHO International Standard (NIBSC code: 89/512).

<0.01 EU per 1 ╡g of the protein by the LAL method.

NP_757350.2

Bioactivity

E. coli -derived human M-CSF protein Glu33-Ser190, with an N-terminal Met Produced using non-animal reagents in an animal-free laboratory.

E. coli

Intended for preclinical researchers who may transition to GMP M-CSF for their clinical work

8175 USD

Intended for preclinical researchers who may transition to GMP M-CSF for their clinical work

colony stimulating factor 1 (macrophage), CSF1, CSF-1, Lanimostim, macrophage colony stimulating factor, macrophage colony-stimulating factor 1, MCSF, M-CSF, MCSFlanimostim, MGC31930

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.